FOLH1 and pachyonychia congenita: Therefore, questions of interest for future study would be whether PSMA PET imaging or genomic classifiers such as the 4K score or the prostate health index [44] designed to assess for the presence of any or aggressive PC, respectively, could enhance earlier detection of clinically significant PC in people with low serum testosterone levels.